NeuroPace, Inc. (NPCE) Social Stream
NEUROPACE INC (NPCE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NPCE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 5 | $30 | $24 | $26.4 | $3.4 | 676.47% |
| 2021-11-11 | 5 | $30 | $17 | $25 | $3.4 | 635.29% |
| 2022-01-07 | 5 | $30 | $12 | $23.4 | $3.4 | 588.24% |
| 2022-02-01 | 5 | $26 | $11 | $17.6 | $3.4 | 417.65% |
| 2022-03-17 | 5 | $26 | $9 | $14.6 | $3.4 | 329.41% |
| 2022-05-13 | 5 | $26 | $6 | $13.833 | $3.4 | 306.85% |
| 2022-08-12 | 4 | $26 | $5.5 | $13.5 | $3.4 | 297.06% |
| 2022-11-09 | 3 | $13 | $3.5 | $9.875 | $3.4 | 190.44% |
| 2022-12-05 | 3 | $13 | $3.5 | $8.875 | $3.4 | 161.03% |
| 2022-12-13 | 3 | $13 | $3.5 | $8.375 | $3.4 | 146.32% |
| 2023-01-06 | 3 | $13 | $2.5 | $8.125 | $3.4 | 138.97% |
| 2023-02-22 | 3 | $13 | $2.5 | $7.875 | $3.4 | 131.62% |
| 2023-03-03 | 3 | $13 | $4.5 | $8.375 | $3.4 | 146.32% |
The Trend in the Analyst Price Target
Over the past 18 months, NPCE's average price target has gone down $19.12.
Over the past 50 weeks, NPCE's average upside potential has been 201.13%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-13 | 5 | 26 | 9.0 | 14.333 | 6.15 | 133.06% |
| 2022-12-05 | 3 | 13 | 3.5 | 8.875 | 1.58 | 461.71% |
| 2023-01-06 | 3 | 13 | 2.5 | 7.166 | 1.58 | 353.54% |
| 2023-01-06 | 2 | 13 | 2.5 | 7.166 | 1.58 | 353.54% |
| 2023-03-03 | 3 | 13 | 4.5 | 8.375 | 4.10 | 104.27% |
NPCE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.1 | 2 | 0 | 0 | 1 | 1 | 3 |
The Trend in the Broker Recommendations
NPCE's average broker recommendation rating worsened by 0.33 over the prior 14 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how NEUROPACE INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1655.08% of that group.
- In terms of how NEUROPACE INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1796.15% of that group.
- To contextualize these metrics, consider that out of all US stocks, NEUROPACE INC's number of analysts covering the stock is greater than 321.95% of them.
- NPCE has a higher average analyst price target than 330.48% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NEUROPACE INC are TMCI, CVRX, and NYXH.
View All Top Stocks by Price Target
What is the outlook for NPCE? Use POWR Ratings for clearer insight into price direction.